德州公路酒吧 TXRH 深 沪
等待开盘 09-24 09:30:00 美东时间
164.84
-1.280
-0.77%
华盛通- 最 高165.78
- 今 开165.55
- 成交量 151.16万股
- 最 低 163.34
- 昨 收 166.12
- 总市值 108.20亿
- 52周最高 215.55
- 市盈率 静 27.03
- 换手率 0.00%
- 52周最低 152.325
- 委 比 29.25%
- 总股本 6564.09万
- 历史最高 215.55
- 量 比 1.24
- 振 幅 1.47%
- 历史最低 -5.67
- 每 手 1
- 风险率 14.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 矿业股获齐声唱多！金田、纽曼矿业等目标价均获上调；携程遭看淡至60美元，较现价仍溢价5成
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从10.25美元升至11美元；Needham：上调Rocket Pharmaceuticals"买入"评级，目标价9美元
09-17 16:16
Seaport Global Initiates Coverage On Texas Roadhouse with Buy Rating, Announces Price Target of $195
Seaport Global analyst Eric Gonzalez initiates coverage on Texas Roadhouse (NASDAQ:TXRH) with a Buy rating and announces Price Target of $195.
09-16 17:24
Soft August dining traffic weighs on restaurant sector
Restaurant stocks are on the defensive Tuesday as industry data showed a meaningful decline in dining traffic, albeit largely driven by the timing of this year’s Labor Day weekend. According to the A...
09-16 02:52
MZTI Fiscal Q4 2026 Earnings Call: Margin Growth and FY2027 Outlook
The Marzetti Company’s fiscal Q4 2026 earnings call covered $465 million in sales, margin expansion, Bachan’s growth and its fiscal 2027 outlook.
08-25 20:00
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
RBC Capital Maintains Outperform on Texas Roadhouse, Raises Price Target to $235
RBC Capital analyst Logan Reich maintains Texas Roadhouse (NASDAQ:TXRH) with a Outperform and raises the price target from $210 to $235.
08-08 04:20
Atlassian To Rally More Than 63%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co raised the price target for Halozyme Therapeutics, Inc. (NASDAQ:HALO) from $95 to $115. HC ...
08-07 20:45
These Analysts Raise Their Forecasts On Texas Roadhouse After Strong Q2 Results
Texas Roadhouse Inc (NASDAQ:TXRH) on Thursday posted better-than-expected earnings for the second quarter. The company reported quarterly earnings of $1.85 per share which beat the analyst consensus estimate of $1.82 per share. The company reported quarterly sales of $1.680 billion which beat the an...
08-07 18:36
Texas Roadhouse declares $0.75 dividend
Texas Roadhouse (TXRH) declares $0.75/share quarterly dividend, in line with previous. Forward yield 1.44% Payable Sept. 29; for shareholders of record Sept. 1; ex-div Sept. 1. See TXRH Dividend Score...
08-07 12:46
